The Global Plasmid DNA Manufacturing Market Size accounted for USD 1.9 Billion in 2023 and is estimated to achieve a market size of USD 10.5 Billion by 2032 growing at a CAGR of 20.9% from 2024 to 2032.
The plasmid DNA manufacturing market is experiencing rapid growth, driven by the increasing demand for gene therapies, vaccine development, and advancements in biotechnology research. Plasmid DNA (pDNA) is a small, circular piece of DNA that is commonly used in genetic research, biotechnology, and the production of therapeutic proteins and vaccines. Due to its versatility, stability, and ability to be replicated in bacterial cells, plasmid DNA plays a vital role in gene therapy applications, vaccine development, and the production of recombinant proteins. The market for plasmid DNA manufacturing is expected to expand significantly over the coming years as the demand for advanced biopharmaceuticals and personalized medicine grows, with an emphasis on cutting-edge gene therapies and DNA-based vaccines.
Plasmid DNA manufacturing involves the extraction, purification, and production of plasmid DNA from bacterial sources, which is then used in a variety of applications, including gene delivery systems, research on genetic disorders, vaccine production, and cell-based therapies. The key factors driving the growth of the plasmid DNA manufacturing market include the increasing adoption of gene therapies for the treatment of genetic diseases, the rising focus on cell and gene therapies in oncology, and the accelerating development of DNA-based vaccines, particularly in response to the COVID-19 pandemic.
Plasmid DNA Manufacturing Market Segmentation
The worldwide market for plasmid DNA manufacturing is split based on grade, disease, development phase, application, and geography.
Plasmid DNA Manufacturing Market By Grade
R&D Grade
Viral Vector Development
Lentivirus
AAV
Retrovirus
Adenovirus
Others
Antibody Development
mRNA Development
DNA Vaccine Development
Others
GMP Grade
Plasmid DNA Manufacturing D Market By Disease
Infectious Disease
Cancer
Genetic Disorder
Plasmid DNA Manufacturing Market By Development Phase
Clinical Therapeutics
Pre-Clinical Therapeutics
Marketed Therapeutics
Plasmid DNA Manufacturing Market By Application
DNA Vaccines
Cell & Gene Therapy
Immunotherapy
Others
Plasmid DNA Manufacturing Market Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)
Plasmid DNA Manufacturing Market Players
Some of the top plasmid DNA manufacturing market companies offered in our report includes Aldevron, Akron Biotech, VGXI, Inc., Nature Technology Corporation, Plasmidfactory GmbH, Cobra Biologics & Pharmaceutical Services, Vigene Biosciences, Luminous Biosciences, JAFRAL Ltd., and Delphi Genetics.
How Acumen Research and Consulting Reserch Study of helps clients in their decision making:
Creating strategies for new product development
Supporting & Adjust Investment/business decisions
Benchmark and judge own competitiveness
Aiding in the business planning process
Serving as a credible, independent check on company internal forecasts
Supporting acquisition strategies
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook